¼öÇ÷¿¹Á¤È¯ÀÚ¿¡¼­ DiaÇ׿øÀ» Æ÷ÇÔÇÑ ºñ¿¹±âÇ×ü ¼±º°°Ë»çÀÇ ÃÖ±Ù 11³â°£ °æÇè
Eleven Years¡¯ Experience with Unexpected Antibody Screening Tests Including a Dia Cell in Transfusion Candidates

´ëÇѼöÇ÷ÇÐȸÁö 2013³â 24±Ç 1È£ p.64 ~ p.70

¿Á¼øÁ¤(Ok Soon-Jung) - ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
±è½Å¿µ(Kim Shine-Young) - ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
±èÀμ÷(Kim In-Suk) - ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
ÀÌÀº¿±(Lee Eun-Yup) - ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
±èÇüȸ(Kim Hyung-Hoi) - ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç

Abstract

Background: The Dia antigen has been detected with a relatively higher incidence among the Korean and Southeast Asian population. A ¡¯Type and Screen¡¯ procedure is recommended for efficient transfusion, therefore, we perform antibody screening tests using antibody screening panels containing a Dia cell. The purpose of this study was to report on the experience of unexpected antibody screening test including a Dia cell in the Korean population.

Methods: We analyzed the results of antibody screening testing and identification performed during the recent 11-year period from January 2002 to December 2012. A commercially available three-cell antigen panel (Diacell I, II, Dia; DiaMed, Murten, Switzerland) was used for antibody screening. Antibodies were identified using a LISS/Coombs gel card and NaCl/Enzyme card, using the DiaMed-ID system (DiaMed, Murten, Switzerland).

Results: The frequency of unexpected antibodies was 1.23% (1,918/156,161); the most frequently detected antibodies were anti-E (292 samples), followed by anti-E,c (127 samples), anti-Lea (103 samples), and anti-Dia (91 samples).

Conclusion: Results of this study showed that the most identified unexpected antibodies were clinically significant, and, in particular, anti-Dia antibodies are detected frequently in the Korean population. Thus, unexpected antibody screening test including a Dia cell is thought to be helpful in Korea for safe transfusion.

Å°¿öµå

Unexpected antibody, Antibody screening test, Anti Dia antibody
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Unexpected antibody screening test including a Dia cell is helpful in Korea for safe transfusion; the most identified unexpected antibodies were clinically significant, and, in particular, anti-Dia antibodies are detected frequently in the Korean population.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå